Search filters

List of works by Jesper Grau Eriksen

A prospective, multicenter DAHANCA study of hyperfractionated, accelerated radiotherapy for head and neck squamous cell carcinoma

scientific article published on 13 September 2019

Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial

scientific article published on 17 May 2018

Competencies in radiation oncology: a new approach for education and training of professionals for Radiotherapy and Oncology in Europe

scientific article published on 04 April 2012

Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients

scientific article published on 17 May 2007

Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab?

scientific article published in April 2010

Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials

scientific article published on 26 July 2011

HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer

scientific article published on 10 November 2009

Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 study.

scientific article

Late onset of skin toxicity induced by EGFr-inhibitors

scientific article published on 17 November 2008

NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy

scientific article published on 21 August 2019

Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial.

scientific article published on 27 August 2005

Prognostic impact of PD-L1 in oropharyngeal cancer after primary curative radiotherapy and relation to HPV and tobacco smoking

scientific article published on 20 February 2020

Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan.

scientific article published on August 2010

Relationship between patient and physician-rated xerostomia and dose distribution to the oral cavity and salivary glands for head and neck cancer patients after radiotherapy

scientific article published on 26 June 2019

The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: Evaluation of the randomised DAHANCA 6&7 trial

scientific article published in July 2011

The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment times

scientific article published on 01 August 2005

The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck

scientific article published in February 2004

The psychosocial work environment among physicians employed at Danish oncology departments in 2009. A nationwide cross-sectional study

scientific article published on October 4, 2012

The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma

scientific article published on 01 January 2005

Tumour hypoxia - a characteristic feature with a complex molecular background

scientific article published on 16 October 2006